Výsledky vyhledávání - "Hypoglycemic Agents/administration"

  1. 1
  2. 2

    Zdroj: Front Endocrinol (Lausanne)
    Frontiers in Endocrinology, Vol 16 (2025)
    Frontiers in endocrinology, vol. 16, pp. 1464532

    Popis souboru: application/pdf

  3. 3

    Přispěvatelé: Othmar Moser Dessi P. Zaharieva Peter Adolfsson a další

    Zdroj: Diabetologia
    Moser, O, Zaharieva, D P, Adolfsson, P, Battelino, T, Bracken, R M, Buckingham, B A, Danne, T, Davis, E A, Dovč, K, Forlenza, G P, Gillard, P, Hofer, S E, Hovorka, R, Jacobs, P G, Mader, J K, Mathieu, C, Nørgaard, K, Oliver, N S, O’Neal, D N, Pemberton, J, Rabasa-Lhoret, R, Sherr, J L, Sourij, H, Tauschmann, M, Yardley, J E & Riddell, M C 2025, ' The use of automated insulin delivery around physical activity and exercise in type 1 diabetes : a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) ', Diabetologia, vol. 68, no. 2, pp. 255–280 . https://doi.org/10.1007/s00125-024-06308-z

    Popis souboru: application/pdf; text/xml; application/zip

  4. 4
  5. 5
  6. 6
  7. 7

    Přispěvatelé: Ruth L M Cordiner Khaled Bedair Andrea Mari a další

    Zdroj: J Clin Endocrinol Metab

    Popis souboru: application/pdf

  8. 8
  9. 9
  10. 10
  11. 11

    Zdroj: FLASH-UK Trial Study Group 2022, 'Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes', The New England Journal of Medicine, vol. 387, no. 16, pp. 1477-1487. https://doi.org/10.1056/NEJMoa2205650

    Popis souboru: application/octet-stream

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Zdroj: Thykjær, A S, Rosengaard, L, Andersen, N, Andresen, J, Hajari, J, Heegaard, S, Højlund, K, Kawasaki, R, Laugesen, C S, Möller, S, Pedersen, F N, Schielke, K, Stokholm, L M & Grauslund, J 2024, 'Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study', Journal of Diabetes and its Complications, vol. 38, no. 9, 108830. https://doi.org/10.1016/j.jdiacomp.2024.108830

    Popis souboru: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/39096767; info:eu-repo/semantics/altIdentifier/pissn/1056-8727; info:eu-repo/semantics/altIdentifier/eissn/1873-460X

  17. 17

    Zdroj: von Herrath, M, Bain, S C, Bode, B, Clausen, J O, Coppieters, K, Gaysina, L, Gumprecht, J, Hansen, T K, Mathieu, C, Morales, C, Mosenzon, O, Segel, S, Tsoukas, G, Pieber, T R & Anti-IL-21–liraglutide Study Group investigators and contributors 2021, 'Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial', The Lancet Diabetes & Endocrinology, vol. 9, no. 4, pp. 212-224. https://doi.org/10.1016/S2213-8587(21)00019-X

    Popis souboru: STAMPA

  18. 18

    Zdroj: CNS Drugs

  19. 19

    Zdroj: BMC Prim Care
    BMC Primary Care, Vol 25, Iss 1, Pp 1-11 (2024)
    BMC primary care, 25(1):124

  20. 20

    Autoři: Ryan, DH Lingvay, I Colhoun, HM a další

    Zdroj: Ryan, D H, Lingvay, I, Colhoun, H M, Deanfield, J, Emerson, S S, Kahn, S E, Kushner, R F, Marso, S, Plutzky, J, Brown-Frandsen, K, Gronning, M O L, Hovingh, G K, Holst, A G, Ravn, H & Lincoff, A M 2020, ' Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design ', American Heart Journal, vol. 229, pp. 61-69 . https://doi.org/10.1016/j.ahj.2020.07.008

    Popis souboru: application/pdf